MEDICYTE

USPTO USPTO 2008 CANCELLED - SECTION 8

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die US-Marke MEDICYTE wurde als Wortmarke am 17.03.2008 beim Amerikanischen Patent- und Markenamt angemeldet.
Sie wurde am 05.06.2012 im Markenregister eingetragen. Der aktuelle Status der Marke ist "CANCELLED - SECTION 8".

Markendetails Letztes Update: 14. August 2019

Markenform Wortmarke
Aktenzeichen 77423742
Registernummer 4152087
Anmeldedatum 17. März 2008
Veröffentlichungsdatum 13. April 2010
Eintragungsdatum 05. Juni 2012

Markeninhaber

Im Neuenheimer Feld 581
69120 Heidelberg
DE

Markenvertreter

Waren und Dienstleistungen

1 Proteins, nucleic acids, genes, and cells for medical research purposes
5 Pharmaceutical and veterinary products for the treatment of cardiovascular disease, stroke, cancer, tumor, namely, by the way of cell and gene therapy; drugs for the treatment of cardiovascular disease, stroke, cancer, tumor, namely, by the way of cell and gene therapy in humans; protein supplements; proteins, nucleic acids, genes, and cells for medical diagnostics and treatment; medical, biological, chemical, biotechnological, and gene-technological products and preparations for medical use for the treatment of cardiovascular disease, stroke, cancer, tumor, namely, by the way of cell and gene therapy; diagnostic preparations for medical and veterinary use
10 Diagnostic devices for medical and veterinary use, namely, for diagnosing cardiovascular disease, stroke, cancer, tumors, diseases of the pancreas, kidney and liver and neurodegenerative diseases
35 Administrative processing of purchase orders in the field of chemistry, biotechnology, diagnostics, and gene-therapy; administrative processing of purchase orders in the field of pharmaceuticals and medicines, medicines for humans, veterinary medicines, and gene-therapy; business consultation services in the field of medicine, all such services limited to primary cell production technology
42 Scientific services for pharmaceutical biotechnological, diagnostic, analytical, medical, or gene-technological laboratories, industrial facilities, research and development facilities in the field of cardiovascular disease, stroke, cancer, tumor, namely, by the way of cell and gene therapy; scientific consulting services in the field of chemistry, biotechnology, diagnostics, and gene-technology, namely, consulting services provided via the Internet; mission-oriented research in the field of chemistry, pharmacy, biotechnology, diagnostics, gene-technology, and medicine; services of a chemical laboratory; conducting of chemical examinations; services of a medical laboratory; medical laboratory services in the nature of conducting medical and clinical trials
44 Medical consultation; consulting services in the field of medicine, namely, human medicine, veterinary medicine, pharmacy, and gene-therapy in the nature of cell therapy; medical consultation services provided via the Internet; medical care; medical information services, namely, laboratory services that report results directly to the patient
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

ID: 1377423742